//Your Connection to the Life Sciences Industry
Connect to IBC:LinkedIn iconTwitter iconFacebook iconBlog iconRSS icon
EmailPrint

Find Another IBC Event

Bioconjugates: From Targets to Therapeutics

CSS

Increase Your Market Share with the Latest Conjugation Design and Manufacturing Science

June 04-06, 2014
Grand Hyatt Hotel
San Francisco, CA

All Access Pass

All Access Pass

Best Value: All Access Pass

Offers you the best ROI for your time and money away from your lab/office.

 

Next Generation Protein Therapeutics Summit

Bioconjugates: From Targets to Therapeutics

Protein Aggregation, Stability & Solubility

AM

Keynote Presentations

Scaffolds at the Frontier of Biologics

Keynote Presentations

ADC Development Challenges and Successes

Keynote Presentations

Understand the Mechanisms of Protein Aggregation

 

Spotlight Presentations

 

Networking Luncheon and "Hot Topic" Roundtable Discussions in the Poster & Exhibit Hall

PM

Bispecific and Multivalent Approaches

Frontiers in Imaging and Radiotherapy

Conjugated Vaccines

Decrease Aggregation Through Engineering

Cutting-Edge Analytical Methods

 

Networking Cocktail Reception in Poster & Exhibit Hall

 

Next Generation Protein Therapeutics Summit

Bioconjugates: From Targets to Therapeutics

Protein Aggregation, Stability & Solubility

AM

Creative Protein Engineering and Design Approaches

Constraining Peptides for More Drug Like Properties

Development of Immunotherapies

Site-Specific Conjugation Through Carbohydrates

Alternate Scaffolds and Delivery Strategies

Minimize Aggregation During Purification

Control Aggregates in Formulation and Fill/Finish

 

Spotlight Presentations

 

Networking Luncheon and "Hot Topic" Roundtable Discussions in the Poster & Exhibit Hall

PM

Next Generation ADCs - Novel Conjugation Technologies, Linkers and Payloads

Towards Homogeneous ADCs - The Promise of Better Clinical Impact and Product Safety

Best Practices to Characterize Particles

 

Next Generation Protein Therapeutics Summit

Bioconjugates: From Targets to Therapeutics

Protein Aggregation, Stability & Solubility

AM

Library Design, Screening, Selection and Display Technologies

Alternatives to PEG for Plasma Half-Life Extension

Platform Approaches

Keynote Presentations

Featured Presentations

Site Specific Conjugation/Novel Linkers and Payloads

Preventing and Managing Aggregation in Bioconjugates

 

Spotlight Presentations

PM

Confront Aggregation Concerns in Early-Stage Development

Approaches to Improve Prediction and Mitigate Risk of Immunogenicity

Targeting Strategies and Protein Delivery Approaches

Cysteine and Selenocysteine Conjugation Strategies for ADCs

Bioconjugate Development

Confront Aggregation Concerns in Early-Stage Development

Approaches to Improve Prediction and Mitigate Risk of Immunogenicity

BPI 2014